US FDA Approved Wysa’s AI Led Device For Mental Health
The Food and Drug Administration (FDA) of the United States has granted approval to a breakthrough device designation of Wysa, an artificial intelligence based platform, for the company’s digital mental health conversational agent based in artificial intelligence for the patients above 18 years along with a diagnosis of the chronic musculoskeletal pain along with depression […]
Continue Reading